6h
GlobalData on MSNRegeneron’s macular oedema therapy shows promise in Phase III trialIn the trial, subjects treated with the Eylea HD 8mg injection every eight weeks showed non-inferior visual acuity gains.
Loss to follow-up higher among men who are Black or Hispanic, or those who must travel farther to care facilities.
The following is a summary of “Evaluating lipid-lowering drug targets for full-course diabetic retinopathy,” published in the ...
Google and Perceptra, a Google technology licensing partner, are joining forces to provide AI-powered diabetic-retinopathy (DR) screening to around 1 million people in underserved communities across ...
A small percentage of patients taking the extraordinarily popular GLP-1 medications have experienced vision problems, but a ...
Sienna Eye Care will provide personalized solutions for eye conditions such as dry eyes, glaucoma, macular pediatric degeneration and diabetic retinopathy. It also will provide pediatric evaluations ...
Maze Therapeutics Inc. has divulged apolipoprotein L1 (APOL1) inhibitors reported to be useful for the treatment of chronic kidney disease, focal segmental glomerulosclerosis, diabetic retinopathy, ...
Scientists remain puzzled as to why some individuals taking popular weight loss and diabetes medications such as Ozempic and ...
THIRUVANANTHAPURAM: Chief Minister Pinarayi Vijayan on Wednesday released a textbook on diabetes management, published by ...
The FDA has approved Susvimo (ranibizumab injection) for the treatment of patients with diabetic macular edema.
A small percentage have had vision problems, but a direct causal link with the drugs has not been established.
AI has demonstrated considerable potential in diabetic foot (DF) management. AI-powered thermal imaging and predictive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results